ÂÜÀòÂÒÂ×

Dr. Geoffrey Hird has more than 20 years of experience in all stages of pharmaceutical product development having held positions at Eisai, GSK, and Liquidia Technologies. In addition to working in industry, Geoff is also an Adjunct Associate Professor at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. His experience spans leading projects on new chemical entities, drug delivery technologies, life cycle management and innovative generics. Dr. Hird earned his B.S. in Chemistry from The College of William and Mary and a Ph.D. in Chemistry from Duke University where his thesis focused on the development of a novel liposomal drug delivery systems.